HintonDM, Food and DrugAdministration. Remdesivir for the treatment of hospitalized 2019 coronavirus disease (COVID-19) patients. Available at https://www.fda.gov/media/137564/download (accessed May3, 2020).
2.
AndersonPO. Breastfeeding and respiratory antivirals: Coronavirus and influenza. Breastfeed Med, 2020; 15:128.
3.
Food and Drug Administration. Fact sheet for health care providers emergency use authorization (EUA) of remdesivir (GS-5734TM). Available at https://www.fda.gov/media/137566/download (accessed May2, 2020).
4.
World Health Organization. Clinical Management of Severe Acute Respiratory Infection (SARI) When COVID-19 Disease Is Suspected. Geneva: World Health Organization, 2020.
BachrachVR, SchwarzE, BachrachLR. Breastfeeding and the risk of hospitalization for respiratory disease in infancy: A meta-analysis. Arch Pediatr Adolesc Med, 2003; 157:237–243.
7.
GeeRE, WoodSF, SchubertKG. Women's health, pregnancy, and the U.S. Food and Drug Administration. Obstet Gynecol, 2014; 123:161–165.
8.
Risks to Reproduction and Offspring. In: MastroianniAC, FadenR, FedermanD, eds. Women and Health Research: Ethical and Legal Issues of Including Women in Clinical Studies: Volume I. Washington, DC: National Academies Press (US), 1994.